Nanoparticles in Cancer Treatment

Nanoparticles are microscopic particles that are less than 100 nanometers in diameter and have a variety of uses in biomedicine including drug delivery, tumor imaging, gene delivery, etc. Here is the latest research on nanoparticles in cancer treatment.

September 17, 2020
Open Access

IRONSperm: Sperm-templated soft magnetic microrobots

Science Advances
Veronika MagdanzSarthak Misra
September 19, 2020
Open Access

A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis

International Journal of Nanomedicine
Zeliang WeiWen Huang
September 20, 2020

Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo

Journal of Nanobiotechnology
Jesse S ChenSu He Wang
September 17, 2020

Fucoidan-Doxorubicin Nanoparticles Targeting P-Selectin for Effective Breast Cancer Therapy

Carbohydrate Polymers
Mina JafariJoo-Youp Lee
September 18, 2020
Open Access

Photothermal and adsorption effects of silver selenide nanoparticles modified by different surfactants in nursing care of cancer patients

Science and Technology of Advanced Materials
Xingju YangGuiqin Zhang
September 18, 2020
Open Access

Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells

International Journal of Molecular Sciences
Sheikh Tanzina HaqueEzharul Hoque Chowdhury
September 19, 2020

Nano-delivery Vehicle Based on Chlorin E6, Photodynamic Therapy, Doxorubicin Chemotherapy Provides Targeted Treatment of HER-2, Negative, ανβ3-positive Breast Cancer

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Zelai HeJingwen Huang
September 17, 2020

Hybrid Nanoplasmonic Porous Biomaterial Scaffold for Liquid Biopsy Diagnostics Using Extracellular Vesicles

ACS Sensors
Tatu RojalinRandy P Carney
September 17, 2020

Tumor Lysis Syndrome After a Single Dose of Atezolizumab with Nab-Paclitaxel: A Case Report and Review of Literature

The American Journal of Case Reports
Xavier CarrierAlexander Philipovskiy
September 16, 2020
Open Access

Induction Heating in Nanoparticle Impregnated Zeolite

Irene MoralesPatricia de la Presa
September 21, 2020

"Exosomes as Biomarkers of Human and Feline Mammary Tumours; A Comparative Medicine Approach to Unravelling the Aggressiveness of TNBC"

Biochimica Et Biophysica Acta. Reviews on Cancer
Jane HowardAmanda McCann
September 20, 2020

Recent advances in development of dendriticpolymer-based nanomedicines for cancer diagnosis

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
Haonan LiKui Luo
September 20, 2020

Drug nanodelivery systems based on natural polysaccharides against different diseases

Advances in Colloid and Interface Science
Abdur RehmanSohail Khan
September 20, 2020

Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer

International Journal of Molecular Sciences
Sangiliyandi GurunathanJin-Hoi Kim

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2020 Meta ULC. All rights reserved